AAM All Access Podcast - Dan Leonard speaks with Mary Beth Powers, President and CEO of CMMB.
  • Access! 2023 - AAM Annual Meeting
    Access! 2023 and 25th IGBA Conference
    Two Conferences – One Location. Make plans to attend Access! 2023 and the 25th IGBA conference, February 13-16 in Orlando, Florida. Meet the leaders and decision-makers who are shaping the future of generics and biosimilars. Take advantage of the early bird promotion with $100 off each conference.
  • GRx+Biosims 2022 - Generics + Biosimilars Conference
    Thanks for Joining us at GRx+Biosims!
    A big thank you to all our sponsors, speakers and attendees who made #GRxBiosims 2022 a success. ICYMI, you can view the highlights on Twitter at #GRxBiosims. The GRx+Biosims conference took place November 7-9 in North Bethesda, Maryland.
  • AAM 2022 U.S. Generic and Biosimilar Medicines Savings Report
    2022 U.S. Generic & Biosimilar Medicines Savings Report
    Savings continue to grow with $373B saved in 2021 the U.S. health care system, including patients, employers, and taxpayers. With 91% of Rx filled and only 18% of Rx drug spending, findings reinforce the critical importance of the generic and biosimilar industry to America’s patients.
  • IQVIA White Paper: Pharmacy Discount Card Utilization and Impact
    Explosive Growth in Drug Discount Cards is a Symptom of a Broken System
    A new white paper from IQVIA shines light not only on the growth of these cards, but also on how much patients are unnecessarily spending on low-cost generic drugs.
  • AAM Voices of Access
    AAM Voices of Access
    Physicians, pharmacists, patients and caregivers across the country trust generics and biosimilars. Here are their stories, in their own words—along with perspectives from health care professionals and the AAM team.
  • Markup Madness
    Who’s Profiting from Your Prescription?
    Unlike brand drugs where the manufacturer stands to profit the most, generic medicines are often exploited by middlemen that seize significant profits at the expense of patients and the companies that make the medicines.

Recent Updates

Dec 2, 2022 | Erica Klinger
Back Together: GRx+Biosims 2022 Conference Recap
Nov 30, 2022 | Erica Klinger
Desi is Back Playing Soccer and Doing "Normal Kid" Stuff
Nov 28, 2022 | Erica Klinger
AAM's Erica Klinger speaks with Connor Nell and Brian Biehn from AmerisourceBergen #GBW2022
Nov 16, 2022 | Erica Klinger
Patient Perspective on the Value of Biosimilars During IGBA #GlobalBiosimilarsWeek

Our Brands and Campaigns

Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.